[Pharmaco-economic aspects of hypolipidemic treatment].
Scheen
A J
AJ
Service de Diabétologie, Nutrition et Maladies métaboliques, Université de Liège.
D000924:Anticholesteremic Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D018803:Models, Economic; D017035:Pravastatin / Q000191:economics / Q000627:therapeutic use; D026712:Value of Life
D000924:Anticholesteremic Agents; D017035:Pravastatin
Aspects pharmaco-économiques des traitements hypolipidémiants.